Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Identification of multiple male reproductive tract-specific proteins that regulate sperm migration through the oviduct in mice.

Fujihara Y, Noda T, Kobayashi K, Oji A, Kobayashi S, Matsumura T, Larasati T, Oura S, Kojima-Kita K, Yu Z, Matzuk MM, Ikawa M.

Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18498-18506. doi: 10.1073/pnas.1908736116. Epub 2019 Aug 27.

2.

The testis-specific serine proteases Prss44, Prss46, and Prss54 are dispensable for mouse fertility.

Holcomb RJ, Oura S, Nozawa K, Kent K, Yu Z, Robertson MJ, Coarfa C, Matzuk MM, Ikawa M, Garcia TX.

Biol Reprod. 2019 Aug 12. pii: ioz158. doi: 10.1093/biolre/ioz158. [Epub ahead of print]

PMID:
31403672
3.

CRISPR/Cas9-mediated genome editing reveals 30 testis-enriched genes dispensable for male fertility in mice†.

Lu Y, Oura S, Matsumura T, Oji A, Sakurai N, Fujihara Y, Shimada K, Miyata H, Tobita T, Noda T, Castaneda JM, Kiyozumi D, Zhang Q, Larasati T, Young SAM, Kodani M, Huddleston CA, Robertson MJ, Coarfa C, Isotani A, Aitken RJ, Okabe M, Matzuk MM, Garcia TX, Ikawa M.

Biol Reprod. 2019 Aug 1;101(2):501-511. doi: 10.1093/biolre/ioz103.

4.

A comprehensive in vitro fluorescence anisotropy assay system for screening ligands of the jasmonate COI1-JAZ co-receptor in plants.

Takaoka Y, Nagumo K, Azizah IN, Oura S, Iwahashi M, Kato N, Ueda M.

J Biol Chem. 2019 Mar 29;294(13):5074-5081. doi: 10.1074/jbc.RA118.006639. Epub 2019 Feb 6.

PMID:
30728246
5.

Seminal vesicle secretory protein 7, PATE4, is not required for sperm function but for copulatory plug formation to ensure fecundity†.

Noda T, Fujihara Y, Matsumura T, Oura S, Kobayashi S, Ikawa M.

Biol Reprod. 2019 Apr 1;100(4):1035-1045. doi: 10.1093/biolre/ioy247.

6.

Engineered CRISPR-Cas9 nuclease with expanded targeting space.

Nishimasu H, Shi X, Ishiguro S, Gao L, Hirano S, Okazaki S, Noda T, Abudayyeh OO, Gootenberg JS, Mori H, Oura S, Holmes B, Tanaka M, Seki M, Hirano H, Aburatani H, Ishitani R, Ikawa M, Yachie N, Zhang F, Nureki O.

Science. 2018 Sep 21;361(6408):1259-1262. doi: 10.1126/science.aas9129. Epub 2018 Aug 30.

7.

Chimeric analysis with newly established EGFP/DsRed2-tagged ES cells identify HYDIN as essential for spermiogenesis in mice.

Oura S, Miyata H, Noda T, Shimada K, Matsumura T, Morohoshi A, Isotani A, Ikawa M.

Exp Anim. 2019 Feb 26;68(1):25-34. doi: 10.1538/expanim.18-0071. Epub 2018 Aug 9.

8.

[Application of Bevacizumab beyond Progressive Disease in Patients with Lung Cancer Recurrence after Surgery].

Yoshimasu T, Oura S, Kawago M, Hirai Y, Ohashi T, Yata Y, Miyasaka M, Nishiguchi H, Aoishi Y, Fusamoto A, Nishimura Y.

Gan To Kagaku Ryoho. 2018 May;45(5):823-827. Japanese.

PMID:
30026445
9.

Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.

Tsuchiya H, Oura S.

Int J Mol Sci. 2018 May 13;19(5). pii: E1450. doi: 10.3390/ijms19051450.

10.

A fundamental study of photoluminescence modulation from DNA-wrapped single-walled carbon nanotubes.

Oura S, Ito M, Homma Y, Umemura K.

Eur Biophys J. 2018 Jul;47(5):523-530. doi: 10.1007/s00249-017-1269-8. Epub 2017 Nov 20.

PMID:
29159501
11.

Radiofrequency Ablation of Breast Cancer: A Retrospective Study.

Ito T, Oura S, Nagamine S, Takahashi M, Yamamoto N, Yamamichi N, Earashi M, Doihara H, Imoto S, Mitsuyama S, Akazawa K.

Clin Breast Cancer. 2018 Aug;18(4):e495-e500. doi: 10.1016/j.clbc.2017.09.007. Epub 2017 Sep 25.

12.

Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.

Kubo H, Hoshi M, Matsumoto T, Irie M, Oura S, Tsutsumi H, Hata Y, Yamamoto Y, Saito K.

Lipids Health Dis. 2017 Jun 3;16(1):106. doi: 10.1186/s12944-017-0501-y.

13.

Adsorption of DNA binding proteins to functionalized carbon nanotube surfaces with and without DNA wrapping.

Ishibashi Y, Oura S, Umemura K.

Eur Biophys J. 2017 Sep;46(6):541-547. doi: 10.1007/s00249-017-1200-3. Epub 2017 Feb 15.

PMID:
28204854
14.

Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.

Iwata H, Masuda N, Yamamoto D, Sagara Y, Sato N, Yamamoto Y, Saito M, Fujita T, Oura S, Watanabe J, Tsukabe M, Horiguchi K, Hattori S, Matsuura Y, Kuroi K.

Breast Cancer Res Treat. 2017 Apr;162(3):501-510. doi: 10.1007/s10549-017-4138-3. Epub 2017 Feb 8.

PMID:
28181129
15.

Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial.

Yamamoto D, Sato N, Rai Y, Yamamoto Y, Saito M, Iwata H, Masuda N, Oura S, Watanabe J, Hattori S, Matsuura Y, Kuroi K.

Breast Cancer Res Treat. 2017 Feb;161(3):473-482. doi: 10.1007/s10549-016-4075-6. Epub 2016 Dec 22.

PMID:
28005247
16.

Physisorption of DNA molecules on chemically modified single-walled carbon nanotubes with and without sonication.

Umemura K, Ishibashi Y, Oura S.

Eur Biophys J. 2016 Sep;45(6):483-9. doi: 10.1007/s00249-016-1116-3. Epub 2016 Feb 4.

PMID:
26846296
17.

Probe Microscopic Studies of DNA Molecules on Carbon Nanotubes.

Umemura K, Izumi K, Oura S.

Nanomaterials (Basel). 2016 Oct 8;6(10). pii: E180. doi: 10.3390/nano6100180. Review.

18.

A Theoretical Model for the Hormetic Dose-response Curve for Anticancer Agents.

Yoshimasu T, Ohashi T, Oura S, Kokawa Y, Kawago M, Hirai Y, Miyasaka M, Nishiguchi H, Kawashima S, Yata Y, Honda M, Fujimoto T, Okamura Y.

Anticancer Res. 2015 Nov;35(11):5851-5.

PMID:
26504007
19.

Class III Beta-tubulin Expression in Non-small Cell Lung Cancer: A Predictive Factor for Paclitaxel Response.

Ohashi T, Yoshimasu T, Oura S, Kokawa Y, Kawago M, Hirai Y, Miyasaka M, Aoishi Y, Kiyoi M, Nishiguchi H, Honda M, Okamura Y.

Anticancer Res. 2015 May;35(5):2669-74.

PMID:
25964544
20.

Biomolecular recognition ability of RecA proteins for DNA on single-walled carbon nanotubes.

Oura S, Ito M, Nii D, Homma Y, Umemura K.

Colloids Surf B Biointerfaces. 2015 Feb 1;126:496-501. doi: 10.1016/j.colsurfb.2015.01.002. Epub 2015 Jan 10.

PMID:
25612818
21.

Primary clear-cell sarcoma in the mediastinum.

Tanaka Y, Yoshimasu T, Oura S, Hirai Y, Kawago M, Okamura Y.

Case Rep Oncol. 2014 May 14;7(2):306-9. doi: 10.1159/000363180. eCollection 2014 May.

22.

Fast Fourier transform analysis of pulmonary nodules on computed tomography images from patients with lung cancer.

Yoshimasu T, Kawago M, Hirai Y, Ohashi T, Tanaka Y, Oura S, Okamura Y.

Ann Thorac Cardiovasc Surg. 2015;21(1):1-7. doi: 10.5761/atcs.oa.13-00318. Epub 2014 Feb 28.

23.

Removal of an endobronchial foreign body using an ultrathin flexible bronchoscope and a novel suction system.

Hirai Y, Oura S, Yoshimasu T, Hirai I, Kokawa Y, Nakamura R, Kawago M, Oohashi T, Nishiguchi H, Honda M, Okamura Y.

J Bronchology Interv Pulmonol. 2013 Oct;20(4):363-4. doi: 10.1097/LBR.0000000000000015. No abstract available.

PMID:
24162126
24.

Targeted delivery of a decoy oligodeoxynucleotide to a single ES cell by femtoinjection.

Funabashi H, Oura S, Saito M, Matsuoka H.

Nanomedicine. 2013 Oct;9(7):855-63. doi: 10.1016/j.nano.2013.03.003. Epub 2013 Mar 16.

PMID:
23506950
25.

Response of meningeal carcinomatosis from breast cancer to capecitabine monotherapy: a case report.

Tanaka Y, Oura S, Yoshimasu T, Ohta F, Naito K, Nakamura R, Hirai Y, Ikeda M, Okamura Y.

Case Rep Oncol. 2013 Jan;6(1):1-5. doi: 10.1159/000345097. Epub 2013 Jan 8.

26.

Preoperative serum pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen level predicts postoperative distant metastasis in patients with non-small-cell lung cancer.

Tanaka Y, Yoshimasu T, Oura S, Hirai Y, Kawago M, Ikeda M, Okamura Y.

Eur J Cardiothorac Surg. 2013 Sep;44(3):539-43; discussion 543. doi: 10.1093/ejcts/ezt076. Epub 2013 Feb 22.

PMID:
23435520
27.

A case of pseudo-meigs' syndrome associated with ovarian metastases from breast cancer.

Naito K, Oura S, Yasuoka H, Okamura Y.

J Breast Cancer. 2012 Dec;15(4):474-7. doi: 10.4048/jbc.2012.15.4.474. Epub 2012 Dec 31.

28.

Surgical treatment for metachronous second primary lung cancer after radical resection of primary lung cancer.

Ishigaki T, Yoshimasu T, Oura S, Ota F, Nakamura R, Hirai Y, Okamura Y.

Ann Thorac Cardiovasc Surg. 2013;19(5):341-4. Epub 2012 Dec 13.

29.

[The importance of p53 and ras mutation as predictive markers for adjuvant chemotherapy in non-small-cell lung cancer].

Hirai Y, Shimizu Y, Oura S, Yoshimasu T, Ota F, Nakamura R, Naito K, Nishiguchi H, Hashimoto S, Okamura Y.

Gan To Kagaku Ryoho. 2012 Mar;39(3):381-4. Japanese.

PMID:
22421763
30.

Exoskeletal meal assistance system (EMAS II) for progressive muscle dystrophy patient.

Hasegawa Y, Oura S.

IEEE Int Conf Rehabil Robot. 2011;2011:5975444. doi: 10.1109/ICORR.2011.5975444.

PMID:
22275644
31.

Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.

Ishitobi M, Ohsumi S, Inaji H, Ohno S, Shigematsu H, Akiyama F, Iwase T, Akashi-Tanaka S, Sato N, Takahashi K, Oura S.

Cancer. 2012 Sep 15;118(18):4385-93. doi: 10.1002/cncr.27377. Epub 2012 Jan 17.

32.

Epidermal growth factor receptor mutations are associated with docetaxel sensitivity in lung cancer.

Yoshimasu T, Oura S, Ohta F, Hirai Y, Naito K, Nakamura R, Nishiguchi H, Hashimoto S, Kawago M, Okamura Y.

J Thorac Oncol. 2011 Oct;6(10):1658-62. doi: 10.1097/JTO.0b013e318221f71a.

33.

Is class III beta-tubulin a true predictive marker of sensitivity to vinorelbine in non-small cell lung cancer? Chemosensitivity data evidence.

Hirai Y, Yoshimasu T, Oura S, Ota F, Naito K, Nishiguchi H, Hashimoto S, Okamura Y.

Anticancer Res. 2011 Mar;31(3):999-1005.

PMID:
21498728
34.

Fibroadenoma of the axillary accessory breast: diagnostic value of dynamic magnetic resonance imaging.

Sawa M, Kawai N, Sato M, Takeuchi T, Tamaki T, Oura S.

Jpn J Radiol. 2010 Oct;28(8):613-7. doi: 10.1007/s11604-010-0466-5. Epub 2010 Oct 24.

PMID:
20972862
35.

[Feasibility of adjuvant docetaxel plus cyclophosphamide therapy for breast cancer].

Naito K, Oura S, Yoshimasu T, Nakamura R, Hirai Y, Kiyoi M, Miyasaka M, Okamura Y.

Gan To Kagaku Ryoho. 2010 Oct;37(10):1913-6. Japanese.

PMID:
20948255
36.

Mediastinal germ cell tumor with acute myeloid leukemia and growing teratoma syndrome.

Hirai Y, Yoshimasu T, Oura S, Okamura Y.

Interact Cardiovasc Thorac Surg. 2011 Jan;12(1):96-7. doi: 10.1510/icvts.2010.242867. Epub 2010 Oct 12.

PMID:
20940164
37.

[Comparison of port needle with safety device between Huber Plus (HP) and Poly PERF Safe (PPS)].

Shimono C, Tanaka A, Fujita A, Ishimoto M, Oura S, Yamaue H, Sato M.

Gan To Kagaku Ryoho. 2010 May;37(5):947-51. Japanese.

PMID:
20495336
38.

Resonant-ultrasound spectroscopy for studying annealing effect on elastic constant of thin film.

Nakamura N, Nakashima T, Oura S, Ogi H, Hirao M.

Ultrasonics. 2010 Feb;50(2):150-4. doi: 10.1016/j.ultras.2009.08.013. Epub 2009 Sep 1.

PMID:
19767053
39.

[Histoculture drug response assay guided adjuvant chemotherapy in patients with ERCC1-positive non-small cell lung cancer].

Hirai Y, Yoshimasu T, Oura S, Tamaki T, Ota F, Nakamura R, Shimizu Y, Naito K, Ota M, Miyasaka M, Okamura Y, Nakamura Y, Yasuoka H, Kodama R.

Gan To Kagaku Ryoho. 2009 Apr;36(4):611-4. Japanese.

PMID:
19381033
40.

Histoculture drug response assay for gefitinib in non-small-cell lung cancer.

Yoshimasu T, Ohta F, Oura S, Tamaki T, Shimizu Y, Naito K, Kiyoi M, Hirai Y, Kawago M, Okamura Y.

Gen Thorac Cardiovasc Surg. 2009 Mar;57(3):138-43. doi: 10.1007/s11748-008-0332-x. Epub 2009 Mar 12.

PMID:
19280309
41.

[Safety and efficacy of weekly paclitaxel followed by FEC100 as primary systemic therapy for breast cancer].

Naito K, Oura S, Yoshimasu T, Tamaki T, Ohta F, Nakamura R, Shimizu Y, Kiyoi M, Hirai Y, Miyasaka M, Okamura Y.

Gan To Kagaku Ryoho. 2009 Feb;36(2):251-4. Japanese.

PMID:
19223740
42.

[Histoculture drug response assay guided concurrent chemoradiotherapy for non-small cell lung cancer].

Tamaki T, Oura S, Yoshimasu T, Ota F, Nakamura R, Shimizu Y, Kiyoi M, Naito K, Hirai Y, Okamura Y.

Kyobu Geka. 2008 Jan;61(1):31-5. Japanese.

PMID:
18186270
43.

In vitro evaluation of dose-response curve for paclitaxel in breast cancer.

Yoshimasu T, Oura S, Hirai I, Tamaki T, Kokawa Y, Ota F, Nakamura R, Shimizu Y, Kawago M, Hirai Y, Naito K, Kiyoi M, Tanino H, Okamura Y, Furukawa T.

Breast Cancer. 2007;14(4):401-5.

44.

[New therapeutic modality for breast cancer: radiofrequency ablation therapy].

Oura S.

Nihon Rinsho. 2007 Jun 28;65 Suppl 6:428-33. Review. Japanese. No abstract available.

PMID:
17682188
45.

[Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with breast cancer].

Tamaki T, Oura S.

Nihon Rinsho. 2007 Jun 28;65 Suppl 6:198-201. Review. Japanese. No abstract available.

PMID:
17682157
46.

Data acquisition for the histoculture drug response assay in lung cancer.

Yoshimasu T, Oura S, Hirai I, Tamaki T, Kokawa Y, Hata K, Ohta F, Nakamura R, Kawago M, Tanino H, Okamura Y, Furukawa T.

J Thorac Cardiovasc Surg. 2007 Feb;133(2):303-8.

47.

Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size.

Oura S, Tamaki T, Hirai I, Yoshimasu T, Ohta F, Nakamura R, Okamura Y.

Breast Cancer. 2007;14(1):48-54.

48.

[Microwave coagulation therapy with potassium titanyl phosphate (KTP) laser therapy for airway stenosis from a recurrent tracheocarinal tumor].

Kinoshita T, Yamamoto S, Hatada A, Tabuse Y, Oura S, Okamura Y.

Kyobu Geka. 2005 Aug;58(9):799-803. Japanese.

PMID:
16104565
49.

Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations.

Yoshimasu T, Miyoshi S, Oura S, Hirai I, Kokawa Y, Okamura Y.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):433-7.

50.

[Cut-off level of docetaxel, paclitaxel and gemcitabine in histoculture drug response assay for non-small cell lung cancer].

Yoshimasu T, Oura S, Hirai I, Kokawa Y, Hata K, Kawago M, Tanino H, Okamura Y, Furukawa T.

Gan To Kagaku Ryoho. 2005 Jul;32(7):1013-6. Japanese.

PMID:
16044964

Supplemental Content

Support Center